Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital

被引:27
作者
Freeman, J
Stott, J
Baines, SD
Fawley, WN
Wilcox, MH [1 ]
机构
[1] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England
[2] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England
关键词
C; difficile; infections; treatment;
D O I
10.1093/jac/dki357
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:988 / 989
页数:3
相关论文
共 10 条
  • [1] Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997
    Barbut, F
    Decré, D
    Burghoffer, B
    Lesage, D
    Delisle, F
    Lalande, V
    Delmée, M
    Avesani, V
    Sano, N
    Coudert, C
    Petit, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2607 - 2611
  • [2] Reduced susceptibility of Clostridium difficile to metronidazole
    Brazier, JS
    Fawley, W
    Freeman, J
    Wilcox, MH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 741 - 742
  • [3] Molecular epidemiology of endemic Clostridium difficile infection
    Fawley, WN
    Wilcox, MH
    [J]. EPIDEMIOLOGY AND INFECTION, 2001, 126 (03) : 343 - 350
  • [4] Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection
    Freeman, J
    Baines, SD
    Jabes, D
    Wilcox, MH
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) : 717 - 725
  • [5] Metronidazole for Clostridium difficile-associated disease:: Is it okay for mom?
    Gerding, DN
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) : 1598 - 1600
  • [6] Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
    Musher, DM
    Aslam, S
    Logan, N
    Nallacheru, S
    Bhaila, I
    Borchert, F
    Hamill, RJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) : 1586 - 1590
  • [7] Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin
    Peláez, T
    Alcalá, L
    Alonso, R
    Rodríguez-Créixems, M
    García-Lechuz, JM
    Bouza, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1647 - 1650
  • [8] Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
    Pépin, J
    Alary, ME
    Valiquette, L
    Raiche, E
    Ruel, J
    Fulop, K
    Godin, D
    Bourassa, C
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) : 1591 - 1597
  • [9] Metronidazole susceptibility in Clostridium difficile isolates recovered from cases of C-difficile-associated disease treatment failures and successes
    Sanchez, JL
    Gerding, DN
    Olson, MM
    Johnson, S
    [J]. ANAEROBE, 1999, 5 (3-4) : 201 - 204
  • [10] Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest
    Wong, SSY
    Woo, PCY
    Luk, WK
    Yuen, KY
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) : 1 - 6